Organigram acquires Aurora Cannabis as Curaleaf exits Australian market
Canadian producer Organigram takes control of Aurora Cannabis operations in Australia while U.S. firm Curaleaf winds down its presence.
FILE — dealmaking · Perzon SEO / CC BY 2.0Organigram has acquired Aurora Cannabis in Australia, marking a significant reshuffling of ownership in the country's medicinal cannabis sector. The deal coincides with Curaleaf International's exit from the Australian market, according to Cannabis News Australia. The acquisition reflects ongoing consolidation among licensed producers competing in a market where regulatory approval pathways remain narrow.
The move occurs as Australian medicinal cannabis faces headwinds from lower-cost imports, per earlier StratCann reporting, while domestic players vie for market share through licensing approvals and product expansion. Recent months have seen competing developments: Yongji Health, a Chinese firm, took control of Australia's largest cannabis farm in September, while Canopy Growth expanded its medical formats in the country. The sector continues to mature under TGA oversight, with new cultivation training and inhalation device approvals signaling regulatory momentum.
Watch whether Organigram's Aurora acquisition includes licensed cultivation assets or primarily distributor/product rights, as this will clarify the company's footprint amid intensifying competition from both domestic vertical farms and international imports.
Original report: Cannabis News Australia ↗